Nrf2 Pathway Activation Compensates for Progranulin Haploinsufficiency in FTD-GRN
🧪 Overview
Repurposing DMF or omaveloxolone to activate Nrf2-ARE pathway, upregulating antioxidant response elements to restore lysosomal function and suppress neuroinflammation in GRN haploinsufficiency. Moderate priority with orphan drug pathway but challenged by prior Nrf2 activator failures in CNS indications.
🧬 Mechanism
⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — NFE2L2
No curated PDB or AlphaFold mapping for NFE2L2 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for NFE2L2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
▸Metadataorigin_type: debate_synthesizer
| origin_type | debate_synthesizer |
| target_gene | NFE2L2 |
| _schema_version | 1 |
| composite_score | 0.63 |